The UK Precision Medicine Catapult

The UK Precision Medicine Catapult's mission is to create the world's leading precision medicine ecosystem. In recognition of the economic growth and improved patient outcomes precision medicine can bring, it is focused on making the UK the most attractive place in the world for the development and delivery of this exciting area of medicine and technology. The Precision Medicine Catapult is headquartered in Cambridge, with regional Centres of Excellence across the UK (Belfast, Cardiff, Glasgow, Leeds, Manchester and Oxford). Working with organisations in these clusters and internationally will enable delivery of its strategy, growing the industry nationally while bringing local healthcare impact.

Key to the Precision Medicine Catapult's aim is the ability to capitalise on the UK's high quality precision medicine infrastructure and regional expertise, so that we can deliver products and services by breaking through the barriers to their translation, adoption and implementation. Our activities will range across clinical trials, device and diagnostic development, regulatory and reimbursement issues, as well as harnessing big data and bioinformatics. We will also be working with a broad range of partners - academics, clinicians, companies, the National Health Service, disease groups and patients. From next generation sequencing to CAR-T therapies, biobanks to patient data records, it is clear that the Precision Medicine Catapult is active in areas in which there is vigorous bioethical debate.  In his remarks Precision Medicine Catapult Chairman Professor Barker will address how the organisation will engage in these debates and influence policy, to ensure that the whole of the UK population benefits from the advent of precision medicine.